Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT05987423 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease
TED

Interventions

DRUG: Satralizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche